CVS Health Boosts Profit Forecast, Aetna Shines

CVS Health Exceeds Expectations: Aetna Unit Drives Profit Boost CVS Health has raised its full-year 2026 profit forecast following a strong first-quarter performance. The company now anticipates adjusted earnings per share between $7.30 and $7.50, up from $7.00 to $7.20. Revenue guidance has also increased to at least $405 billion from $400 billion, and cash flow from operations has been raised to at least $9.5 billion from $9 billion. The primary catalyst for this positive development was the companys Aetna insurance unit, where medical costs were better managed than expected. The medical benefit ratio dropped to 84.6% from 87.3% last year, surpassing analyst expectations of 86.3%. This improvement led to adjusted operating income surging 52.6% to $3.04 billion. CVS has now exceeded Wall Street expectations for five consecutive quarters, a significant turnaround after several misses in 2024 that resulted in a CEO change. Investors are optimistic as CVS demonstrates progress in controlling healthcare expenses. The health services segment, which includes Caremark, saw revenue grow 11% to $48.24 billion due to a more favorable drug mix. Pharmacy and consumer wellness sales remained stable at $31.99 billion, but operating income decreased 8.8% due to reimbursement pressures, drug pricing rules, a mild flu season, and weather disruptions. CVSs CFO attributes the companys success to improved forecasting tools and internal adjustments. Despite anticipating higher medical costs in the future, Aetnas strong performance has positioned CVS favorably for the year. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b44b804596d1ad01